New diabetes study in London

A London doctor, Stuart Harris, is putting together a trial to see whether two diabetes drugs combined are more effective than the individual substances in preventing type 2 diabetes.
Dr. Harris, who is to lead the research in London and Toronto, said: “It may turn out to be a great medication.” The study will combine Avandia and Glucophage, and test whether Avandamet works to prevent type 2 diabetes. Avandamet is currently used to treat the condition, but hasn’t been trailed as a preventative drug.
Avandia and Glucophage have both been found to be effective in the prevention of type 2 diabetes, although not together. Harris said: “It is our hunch the two combined pills in one tablet will be very effective.”
People who wish to enrol in the study are to be given a simple blood test to see if they are at risk of diabetes. Participants will then be given one-on-one sessions with a diabetes nurse and half will be given the combined pills.
Dr. Harris and team are looking for individuals who have a risk of developing type 2 diabetes. Risk factors include being overweight, having a family history of diabetes, high blood pressure, gestational diabetes or having a baby that weighed more than nine pounds.